Product Information
TUSSIN CF MAX SEVERE M-S COLD is a generic product labeled by Cardinal Health, priced at $0.0241 per ML under NDC 70000062301. Its NADAC has been published 107 times since Sep 18, 2024.
TUSSIN CF MAX SEVERE M-S COLD
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine HydrochlorideStrength
650; 20; 400; 10 mg/20mL; mg/20mL; mg/20mL; mg/20mL
Manufacturer
Cardinal HealthNDC
70000062301
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/31/2023
Pharmacological Classes
Price Statistics
The NADAC for TUSSIN CF MAX SEVERE M-S COLD has been published 107 times since Sep 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0241 per ML |
|---|---|
| All-time high | $0.0251 (Aug 13, 2025) |
| All-time low | $0.0230 (Jan 21, 2026) |
| 52-week high | $0.0245 |
| 52-week low | $0.0230 |
| Median price | $0.0241 |
| Average price | $0.0240 |
| Largest weekly change | +3.5% (Jun 18, 2025) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TUSSIN CF MAX SEVERE M-S COLD?
The current National Average Drug Acquisition Cost (NADAC) for TUSSIN CF MAX SEVERE M-S COLD, manufactured by Cardinal Health, is $0.0241 per ML (NDC 70000062301), effective Sep 30, 2026.
How has the price of TUSSIN CF MAX SEVERE M-S COLD changed over time?
Over the history we have for it, the NADAC for TUSSIN CF MAX SEVERE M-S COLD has held within roughly two percent of its current level. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for TUSSIN CF MAX SEVERE M-S COLD?
Since Sep 18, 2024, the NADAC for TUSSIN CF MAX SEVERE M-S COLD has ranged from a low of $0.0230 (Jan 21, 2026) to a high of $0.0251 (Aug 13, 2025), with a median of $0.0241 per ML.
Are there cheaper alternatives to TUSSIN CF MAX SEVERE M-S COLD?
No other NADAC-published product currently shares the active ingredient and strength of TUSSIN CF MAX SEVERE M-S COLD in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TUSSIN CF MAX SEVERE M-S COLD?
TUSSIN CF MAX SEVERE M-S COLD (NDC 70000062301) is labeled by Cardinal Health, and CMS classifies it as a generic product.